Spectral AI (MDAI) Free Cash Flow Growth (3y) (2024 - 2026)
Spectral AI (MDAI) Free Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 9.23% |
| 10 | Spectral AI | 50.69 Mn | 36.69 Mn | 1.11 Mn | -32.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.23% |
| Mar 31, 2026 | 0.24% |
| Dec 31, 2025 | -104.36% |
| Sep 30, 2025 | -98.59% |
| Jun 30, 2025 | -141.00% |
| Mar 31, 2025 | -70.52% |
| Dec 31, 2024 | 91.03% |
| Sep 30, 2024 | -591.48% |
| Jun 30, 2024 | -110.32% |
| Mar 31, 2024 | -161.43% |